Company news: Chandler Chicco, EMA
Two months after supporting a “breach of trusts” procedure the European Medicines Agency approves a set of rules for how to deal with board members who incorrectly report or downplay their affiliations. This procedure complements its March 2012 policy which for identifying potential conflicts of interest. The EMA requires staff and agency members to provide declarations of interest annually. It also assigns risk levels for potential committee members after examining an annual form in which experts indicate the nature of their interests, the duration and the type of activity the expert may undertake on behalf of the EMA.